✦ LIBER ✦

Increased paclitaxel resistance in recurrent epithelial ovarian cancer: analysis of metachronous tumors

✍ Scribed by Koji Matsuo; Dwight D. Im; Neil B. Rosenshein

Publisher: Springer
Year: 2010
Tongue: English
Weight: 129 KB
Volume: 15
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-010-0032-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of chemotherapy for patients with r

Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer : A cost-effectiveness analysis

✍ Rodney P. Rocconi; Ashley S. Case; J. Michael Straughn Jr.; Jacob M. Estes; Edwa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

Glycoproteomics of paclitaxel resistance

Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers

✍ Michela Di Michele; Simone Marcone; Lucia Cicchillitti; Anna Della Corte; Cristi 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 432 KB

A phase 1 and pharmacodynamic study of d

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

✍ Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

## Abstract ## BACKGROUND: Aberrant DNA methylation is a hallmark of cancer, and DNA methyltransferase inhibitors have demonstrated clinical efficacy in hematologic malignancies. On the basis of preclinical studies indicating that hypomethylating agents can reverse platinum resistance in ovarian c

A pilot study evaluating the efficacy an

A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer

✍ Faruk Tas; Nese Guney; Duygu Derin; Adnan Aydiner; Erkan Topuz 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 208 KB

Tissue array analysis of expression micr

Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer

✍ Véronique Ouellet; Marie-Claude Guyot; Cécile Le Page; Abdelali Filali-Mouhim; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 368 KB 👁 2 views

## Abstract Molecular profiling is a powerful approach to identify potential clinical markers for diagnosis and prognosis as well as providing a better understanding of the biology of epithelial ovarian cancer. On the basis of the analysis of HuFL expression data, we have previously identified gene

Quantitative analysis of follicle-stimul

Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: A novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems

✍ Jun Wang; Lynne Lin; Vinita Parkash; Peter E. Schwartz; Stuart C. Lauchlan; Wenx 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 201 KB

## Abstract The role of FSHR expression in ovarian cancer development is not clear. We examined quantitative expression of FSHR in different types of OET, presumed precursor lesions and peritoneal implants and further discussed FSH as a key growth‐promotion factor for the process of ovarian epithel